Govt approves investment by FIL Capital in Cipla Health
New Delhi : Drug major Cipla said the government has approved an investment by Mauritius-based FIL Capital Investments in its subsidiary, Cipla Health Ltd.
"...It appears that the government has, based on the recommendations of the Foreign Investment Promotion Board, approved the proposed investment by FIL Capital Investments (Mauritius) II Ltd in Cipla Health Ltd, subsidiary of the company," Cipla said in a BSE filing.
The investment is still subject to other conditions precedent and the transfer of company's consumer healthcare business to Cipla Health Ltd, it added.
The government yesterday approved 10 foreign investment proposals involving an inflow of Rs 607 crore, including Cipla's proposal of Rs 145.22 crore.
In November last year, Cipla said in a regulatory filing that Cipla Health Ltd and FIL Capital Investments (Mauritius) II Ltd have signed an investment agreement for its consumer healthcare business.
"...It appears that the government has, based on the recommendations of the Foreign Investment Promotion Board, approved the proposed investment by FIL Capital Investments (Mauritius) II Ltd in Cipla Health Ltd, subsidiary of the company," Cipla said in a BSE filing.
The investment is still subject to other conditions precedent and the transfer of company's consumer healthcare business to Cipla Health Ltd, it added.
The government yesterday approved 10 foreign investment proposals involving an inflow of Rs 607 crore, including Cipla's proposal of Rs 145.22 crore.
In November last year, Cipla said in a regulatory filing that Cipla Health Ltd and FIL Capital Investments (Mauritius) II Ltd have signed an investment agreement for its consumer healthcare business.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.